type 1 diabetes

Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Diabetes: Are we underestimating its prevalence?A new report shatters earliest estimates that just 0.25% of teens have diabetes, placing that figure closer to 1% plus an estimated 17.7% with prediabetes.
Pitfalls in pediatric type 1 diabetes care
Pitfalls in pediatric type 1 diabetes careType 1 diabetes accounts for over 90% of diabetes in children and adolescents worldwide, and it is estimated that about 78,000 young persons are diagnosed annually.
CPF: A funding resource for community pharmacies
CPF: A funding resource for community pharmaciesCPF puts its money where its mission is.
New therapy to fight pediatric hypoglycemiaFor parents of a child with type 1 diabetes, hypoglycemia can be a scary—and fatal—complication, but a treatment is in development that gives parents and caregivers a new way to keep glucose levels in check.
"Smart" patch may eliminate need for insulin shots in diabeticsA new, painless “smart insulin patch” lowered blood glucose in a mouse model of type 1 diabetes for up to 9 hours, according to a study published in the Proceedings of the National Academy of Sciences.
Patients: Trust your doctor, not public figuresFormer Arkansas governor Mike Huckabee is not an expert on diabetes, but he's telling patients he is a better resource than their own physician.
New, more potent diabetes drug approved by FDAFDA has approved a new once-daily, long-acting basal insulin, Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL, Sanofi) for the treatment of adults with type 1 and type 2 diabetes mellitus. It is described as a more potent follow-up to the manufacturer’s insulin product Lantus (insulin glargine [rDNA origin] injection, 100 U/mL).
High blood glucose in kids may slow brain growthChildren with chronically high blood glucose levels are more likely to show slower brain growth than children with normal glucose levels, a new study has found.